Medtronic
MDT
1,990 hedge funds and large institutions have $88B invested in Medtronic in 2023 Q1 according to their latest regulatory filings, with 186 funds opening new positions, 992 increasing their positions, 620 reducing their positions, and 119 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 992 | Existing positions reduced: 620
56% more first-time investments, than exits
New positions opened: 186 | Existing positions closed: 119
20% more call options, than puts
Call options by funds: $666M | Put options by funds: $555M
1% more funds holding
Funds holding: 1,961 → 1,990 (+29)
4% more capital invested
Capital invested by funds: $84.7B → $88B (+$3.25B)
0.59% more ownership
Funds ownership: 81.43% → 82.01% (+0.59%)
13% less funds holding in top 10
Funds holding in top 10: 31 → 27 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$281M |
| 2 |
First Eagle Investment Management
New York
|
+$271M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$252M |
| 4 |
CCM
Cullen Capital Management
New York
|
+$246M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$234M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$375M |
| 2 |
Barclays
London,
United Kingdom
|
-$341M |
| 3 |
D.E. Shaw & Co
New York
|
-$198M |
| 4 |
Two Sigma Investments
New York
|
-$162M |
| 5 |
Renaissance Technologies
New York
|
-$136M |
MDT Hedge Fund Activity: Q1 2023 in Review
1,990 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2023, worth a combined $88B — up 3.8% from $84.7B a quarter earlier.
Buyers outnumbered sellers: 186 funds opened new MDT positions and 119 closed out — a net gain of 67 holders — while 992 added to existing stakes and 620 trimmed.
The largest buyer was Ameriprise, adding an estimated $281M. The largest seller was BlackRock, cutting an estimated $375M.
- 1,990 institutional investors held Medtronic (MDT) as of Q1 2023, up from 1,961 in Q4 2022.
- Funds reported $88B of Medtronic stock for Q1 2023, up 3.8% quarter-over-quarter.
- 186 funds opened new Medtronic positions in Q1 2023 and 119 closed out, a net change of +67 holders.
- The largest Medtronic buyer in Q1 2023 was Ameriprise, an estimated $281M added.
- The largest Medtronic seller in Q1 2023 was BlackRock, an estimated $375M sold.
Based on aggregated 13F filings for Q1 2023.